David R. Hoffmann

David R. Hoffmann has served as a Director since December 2002 and was appointed Chairman of the Board effective January 1, 2019. Mr. Hoffmann served as Lead Independent Director from December 2010 to December 2018. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 until his retirement in October 2002, Vice President of Finance from 1982 to 1992, and Director of Accounting/Finance from 1976 to 1982. Mr. Hoffmann is currently Chief Executive Officer of Hoffmann Associates, a multigroup company specializing in cruise travel and financial and benefits consulting. Mr. Hoffmann holds a Bachelor of Science in business administration from the University of Colorado. Mr. Hoffmann is currently a member of the board of directors and Chairman of the audit committee of Molecular Templates, an oncology company. Mr.  Hoffmann’s financial and accounting expertise has caused the board to designate him as the audit committee’s financial accounting expert. In addition, his pharmaceutical industry experience relating to executive management, treasury, employee benefits, and audit matters is an additional qualification he brings to the board and his service as a Director of the company.